Agilon Health Company Leadership

AGL Stock  USD 3.36  0.27  7.44%   
Agilon Health's insiders are aggressively buying. The analysis of insiders' sentiment of trading agilon health stock suggests that most insiders are extremely bullish at this time. Agilon Health employs about 31 people. The company is managed by 31 executives with a total tenure of roughly 105 years, averaging almost 3.0 years of service per executive, having 1.0 employees per reported executive.

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2024-12-13Karen McloughlinAcquired 25000 @ 2.2View
2024-12-09Diana MckenzieAcquired 7500 @ 2.2View
2024-12-05John William WulfAcquired 45000 @ 2.18View
2024-11-25Diana MckenzieAcquired 12500 @ 2.28View
2024-09-12Steven SellAcquired 20000 @ 3.36View
Monitoring Agilon Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

Agilon Health Management Team Effectiveness

The company has Return on Asset of (0.1038) % which means that on every $100 spent on assets, it lost $0.1038. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.4422) %, meaning that it generated no profit with money invested by stockholders. Agilon Health's management efficiency ratios could be used to measure how well Agilon Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.17. The value of Return On Capital Employed is expected to slide to -0.53. At this time, Agilon Health's Net Tangible Assets are quite stable compared to the past year. Other Current Assets is expected to rise to about 46.9 M this year, although the value of Non Current Assets Total will most likely fall to about 240.5 M.
Common Stock Shares Outstanding is expected to rise to about 442 M this year, although the value of Net Loss will most likely fall to (128.7 M).

Agilon Health Workforce Comparison

agilon health is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 303,878. Agilon Health adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Agilon Health Profit Margins

The company has Net Profit Margin of (0.04) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.07) %, which entails that for every $100 of revenue, it lost $0.07.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin8.0E-48.0E-4
Notably Down
Slightly volatile

Agilon Health Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agilon Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agilon Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Agilon Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
5.0
5
1
 918,952 
 405.00 
2024-06-01
2.8333
17
6
 2,338,182 
 26,042 
2024-03-01
1.0
7
7
 1,412,224 
 1,210,683 
2023-09-01
0.3182
7
22
 97,812 
 330,465 
2023-06-01
1.0294
35
34
 616,415 
 94,926,820 
2023-03-01
0.5
24
48
 722,409 
 1,339,014 
2022-12-01
0.4167
15
36
 139,641 
 395,478 
2022-09-01
0.3913
9
23
 190,585 
 23,591,861 
2022-06-01
0.7273
16
22
 326,642 
 702,945 
2022-03-01
0.1667
1
6
 37,155 
 538,054 
2021-12-01
0.3333
8
24
 240,000 
 526,970 
2021-09-01
0.5263
10
19
 713,277 
 20,168,380 
2021-06-01
0.7778
28
36
 710,821 
 16,950,000 
2011-12-01
1.8
18
10
 38,343 
 14,346 
2011-06-01
11.0
22
2
 23,178 
 4,014 
2010-09-01
7.0
7
1
 1,851 
 789.00 
2010-03-01
4.5
9
2
 34,116 
 5,806 
2009-12-01
2.6667
16
6
 7,076 
 3,737 
2008-09-01
0.5
6
12
 389.83 
 1,847,797 
2008-06-01
12.0
12
1
 7,051 
 2,000 
2007-06-01
0.1852
5
27
 5,503 
 336,480 
2006-06-01
8.6667
26
3
 161,708 
 3,665 
2006-03-01
13.0
13
1
 72,031 
 0.00 
2005-06-01
21.0
21
1
 81,123 
 76.00 
2004-06-01
18.0
18
1
 37,066 
 0.00 

Agilon Health Notable Stakeholders

An Agilon Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Agilon Health often face trade-offs trying to please all of them. Agilon Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Agilon Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Steven SellPresident, Chief Executive Officer, DirectorProfile
Ronald WilliamsNon-Executive Chairman of the BoardProfile
Jeffrey CPAExecutive CFOProfile
Timothy BensleyChief Financial OfficerProfile
Girish VenkatachaliahChief Technology OfficerProfile
Timothy GertschController VPProfile
Benjamin ShakerChief OfficerProfile
Bill FarryChief InnovationProfile
Derek StrumDirectorProfile
Michelle GourdineIndependent DirectorProfile
Denise ZamoreChief SecretaryProfile
Sharad MansukaniIndependent DirectorProfile
Michael SmithIndependent DirectorProfile
William WulfDirectorProfile
Mat VargheseChief OfficerProfile
Benjamin KornitzerChief Medical and Quality OfficerProfile
Claire MulhearnChief OfficerProfile
Ben ShakerChief Markets OfficerProfile
Joan DanieleyChief Administrative OfficerProfile
Matthew CFAVice RelationsProfile
Lisa AliChief OfficerProfile
Lisa DombroChief Experience and Innovation OfficerProfile
Ravi SachdevVice Chairman of the BoardProfile
Karen McloughlinDirectorProfile
Priscilla KasenchakChief OfficerProfile
Chris CaslerChief Human Resource OfficerProfile
Leland ThomasSenior RelationsProfile
Clay RichardsIndependent DirectorProfile
Veeral DesaiChief Strategy and Development OfficerProfile
Richard SchnallDirectorProfile
Theodore HalkiasChief Business OfficerProfile

About Agilon Health Management Performance

The success or failure of an entity such as agilon health often depends on how effective the management is. Agilon Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Agilon management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Agilon management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.16)(0.17)
Return On Capital Employed(0.50)(0.53)
Return On Assets(0.15)(0.16)
Return On Equity(0.55)(0.52)

Agilon Health Workforce Analysis

Traditionally, organizations such as Agilon Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Agilon Health within its industry.

Agilon Health Manpower Efficiency

Return on Agilon Health Manpower

Revenue Per Employee195.5M
Revenue Per Executive195.5M
Net Loss Per Employee8.4M
Net Loss Per Executive8.4M
Working Capital Per Employee9.9M
Working Capital Per Executive9.9M
When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in agilon health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
11.951
Earnings Share
(0.70)
Revenue Per Share
14.747
Quarterly Revenue Growth
0.442
Return On Assets
(0.10)
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.